Table 1 Epidemiology and the impact of multifaceted bundle approach in controlling CVC-ABSIs in non-ICU inpatients, year before and three years after the intervention
Years | p | ||||
|---|---|---|---|---|---|
2008 | 2009 | 2010 | 2011 | ||
Prevalence use of central line | 15/632 (2.4%) | 13/616 (2.1%) | 11/573 (1.92%) | 8/649 (1.2%) | 0.50 |
Surgery ward# | 5/120 (4.2%) | 4/115 (3.5%) | 5/133 (3.8%) | 5/118* (4.2%) | 0.99 |
Internal medicine ward# | 5/266 (1.9%) | 6/290 (2.1%) | 3/276 (1.1%) | 3/334* (0.9%) | 0.57 |
Estimated number of catheter-days | 2,587 | 2,233 | 2,176 | 1,285 | <0.05 |
Prevalence use of parenteral nutrition by central line | 8/15 (53.3%) | 5/13 (38.5%) | 5/11 (45.5%) | 6/8 (75%) | 0.83 |
Surgery ward# | 4/5 (80%) | 3/4 (75%) | 4/5 (80%) | 5/5 (100%) | 0.99 |
Internal medicine ward# | 2/5 (40%) | 0/6 (0%) | 0/3 (0%) | 1/3 (33.3%) | 0.41 |
Mean age ± SD | 60.2 ± 20.9 | 63.2 ± 19.5 | 64.9 ± 19.9 | 65.9 ± 18.5 | <0.05 |
Mean length of stay (days) in surgery ward | 10.93 | 10.61 | 10.98 | 10.37 | 0.97 |
Mean length of stay (days) in internal medicine ward | 9.58 | 9.36 | 9.33 | 9.17 | 0.95 |
CVC-ABSIs surveillance | |||||
No. of blood cultures performed/1,000 inpatient-days | 23.3 | 27.1 | 29.5 | 29.2 | |
No. of CVC-ABSIs / No. of blood cultures performed | 39/2880 | 25/3275 | 23/3483 | 11/3422 | <0.001 |
Positive catheter tip culture | 27/39 (69.2%) | 18/25 (72%) | 14/23 (60.9%) | 11/11 (100%) | 0.83 |
No. CVC-ABSIs /1,000 catheter-days | 15.1 | 11.2 | 10.6 | 8.6 | |
Surgery ward | 18.9 | 20.2* | 14.1 | 8.9 | |
Internal medicine ward | 14.1 | 2.8* | 8.7 | 4 | |
Alcohol-based handrubs consumption. L/1,000 inpatient-days | 2.34 | 6.07 | 3.5 | 5,2 | |
Surgery ward | 1.1 | 5.6 | 3.76 | 4.6 | |
Internal medicine ward | 2.2 | 6.78 | 4.64 | 4.97 | |